AC-262536

Other names: AC-262,536, 4-(3-endo-hydroxy-8-azabicyclo(3.2.1)oct-8-yl)naphthalene-1-carbonitrile

Classifications: 6000

Reasons for prohibition: - WADA S1: Anabolic Agents (source) - FDA Statement - Unapproved Drug

References: - {'title': 'FDA warns against using SARMs in body-building products', 'url': 'https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products'} - {'title': 'NIH NCATS Inxight Drugs entry: AC-262536', 'url': 'https://drugs.ncats.io/drug/U8VS41J5O6'}

Reason: WADA S1: Anabolic Agents; Unapproved drug; FDA statement: SARMs

Label terms: []

Searchable name: ac-262536

GUID: 26ce4b2c-b21b-4244-be4d-b1eeb03e1475

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1738867231, "_nanoseconds": 923000000}